Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.1.1.4 extracted from

  • Pan, Y.H.; Bahnson, B.J.
    Structural basis for bile salt inhibition of pancreatic phospholipase A2 (2007), J. Mol. Biol., 369, 439-450.
    View publication on PubMedView publication on EuropePMC

Activating Compound

Activating Compound Comment Organism Structure
cholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa
glycochenodeoxycholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa
glycocholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa
taurochenodeoxycholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa
taurocholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa

Crystallization (Commentary)

Crystallization (Comment) Organism
pancreatic PLA2 in complex with five different naturally occurring bile salts, i.e. cholate, taurocholate, glycocholate, glycochenodeoxycholate, and taurochenodeoxycholate, in presence or absence of active-site-directed tetrahedral mimic MJ33, hanging drop vapour diffusion method, 15 mg/ml protein solution with 10 mM CaCl2, 3 mM MJ33, and 3 mM bile salt, is mixed with an equal volume of 0.001 ml of cyrstallization solution containing 0.2 M CaCl2, 0.1 M HEPES, pH 7.5, and 28% v/v PEG 400 or 0.1 M sodium cacodylate, pH 6.5, and 1.4 M sodium acetate, 1 week to 2 months, X-ray diffraction structure determination and analysis at 1.85-2.20 A resolution, modeling Sus scrofa

Inhibitors

Inhibitors Comment Organism Structure
cholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa
glycochenodeoxycholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa
glycocholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa
MJ33 i.e. 1-hexadecyl-3-(trifluoroethyl)-rac-glycero-2-phosphomethanol, an active-site-directed tetrahedral mimic Sus scrofa
taurochenodeoxycholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa
taurocholate bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
additional information Sus scrofa bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview ?
-
?

Organism

Organism UniProt Comment Textmining
Sus scrofa P00592
-
-

Source Tissue

Source Tissue Comment Organism Textmining
pancreas
-
Sus scrofa
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information bile salt regulation of lipid metabolism via both activation and inhibition of PLA2, interaction and binding structure analysis, overview Sus scrofa ?
-
?

Synonyms

Synonyms Comment Organism
pancreatic phospholipase A2
-
Sus scrofa